Originally published In Press as doi:10.1074/jbc.M111809200 on March 13, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18523-18527, May 24, 2002
Importance of the Histidine Ligand to Coenzyme B12 in
the Reaction Catalyzed by Methylmalonyl-CoA Mutase*
Monica
Vlasie,
Shantanu
Chowdhury, and
Ruma
Banerjee
From the Department of Biochemistry, University of Nebraska,
Lincoln, Nebraska 68588-0664
Received for publication, December 11, 2001, and in revised form, March 7, 2002
 |
ABSTRACT |
Methylmalonyl-CoA mutase is an adenosylcobalamin
(AdoCbl)-dependent enzyme that catalyzes the rearrangement
of methylmalonyl-CoA to succinyl-CoA. The crystal structure of this
protein revealed that binding of the cofactor is accompanied by a
significant conformational change in which dimethylbenzimidazole, the
lower axial ligand to the cobalt in solution, is replaced by His-610
donated by the active site. The contribution of the lower axial base to
the ~1012-fold rate acceleration of the homolytic
cleavage of the upper axial cobalt-carbon bond has been the subject of
intense scrutiny in the model inorganic literature. In contrast,
trans ligand effects in methylmalonyl-CoA mutase and indeed
the significance of the ligand replacement are poorly understood. In
this study, we have used site-directed mutagenesis to create the H610A
and H610N variants of methylmalonyl-CoA mutase and report that both
mutations exhibit both diminished activity (5,000- and 40,000-fold,
respectively) and profoundly weakened affinity for the native cofactor,
AdoCbl. In contrast, binding of the truncated cofactor analog,
adenosylcobinamide, lacking the nucleotide tail, is less impaired. The
catalytic failure of the His-610 mutants is in marked contrast to the
phenotype of the adenosylcobinamide-GDP reconstituted wild type enzyme
that exhibits only a 4-fold decrease in activity, although His-610 fails to coordinate when this cofactor analog is bound. Together, these
studies suggest that His-610 may: (i) play a structural role in
organizing a high affinity cofactor binding site possibly via
electrostatic interactions with Asp-608 and Lys-604, as
suggested by the crystal structure and (ii) play a role in catalyzing
the displacement of dimethylbenzimidazole thereby facilitating the conformational change that must precede cofactor docking to the mutase
active site.
 |
INTRODUCTION |
Coenzyme B12 or
AdoCbl1-dependent
enzymes catalyze a wide variety of isomerization reactions in which a
migrating group and a hydrogen atom on vicinal carbons exchange
positions. A common function of the cofactor in these reactions is to
serve as a dormant source of radicals that is activated by homolysis of
the organometallic Co-C bond upon substrate binding. The uncatalyzed
rate for the cleavage of the Co-C bond in the cofactor free in
solution is 3.8 × 10
9 s
1 at 37 °C
(1). In contrast, the kcat for most
AdoCbl-dependent enzymes is of the order of
~102 s
1 leading to a predicted rate
enhancement that is of the order of 1012-fold (2). A member
of this class of enzymes is methylmalonyl-CoA mutase, which catalyzes
the 1,2 rearrangement of methylmalonyl-CoA to succinyl-CoA (reviewed in
Ref. 3). It is distinguished by being the only family member that is
found in both bacterial and mammalian organisms. Methylmalonyl-CoA
mutase catalyzes a 0.9 × 1012-fold enhancement of the
homolysis rate that corresponds to a lowering of the activation barrier
by 17 kcal/mol at 37 °C (4).
Unlike the porphyrins and chlorins, other members of the family of
tetrapyrrolic-derived cofactors, cobalamins are characterized by the
presence of a large peripheral ornamentation appended from ring D, the
dimethylbenzimidazole-containing nucleotide loop. In solution and at
physiological pH, AdoCbl is six-coordinate, and the lower axial ligand
is the bulky and weakly basic intramolecular base,
dimethylbenzimidazole (5). However, in the class I or "His-on" (3)
subfamily of AdoCbl-dependent enzymes, this lower ligand is
replaced by a histidine residue provided by the respective proteins (6,
7), while the dimethylbenzimidazole moiety is held >10 Å away from
the cobalt. This ligand switch was first reported in
B12-dependent methyltransferases that catalyze
heterolytic cleavage of the Co-C bond (8, 9). In contrast, the class II or "dmb-on" enzymes retain the intramolecular ligand in their bound conformation (10-12).
The potential role of the lower axial ligand in labilizing the upper
axial Co-C bond has been the focus of enduring debate. A popular
hypothesis to explain the observed rate enhancement invokes the role of
conformational distortion of the corrin macrocycle (for example, see
Refs. 13-18). According to this "mechanochemical" mechanism for
labilization of the Co-C bond, an upward flexing of the corrin ring
would lead to steric crowding on the
-face thereby weakening the
organometallic bond.
The influence of the trans electronic effects on the
cobalt-alkyl bond dissociation energies have been determined with
phenylethylcobalt dimethylglyoxime model compounds in which in a series
of substituted pyridines were employed as the trans ligand
(16). These studies revealed a linear correlation between increasing
basicity of the trans ligand and increasing stabilization of
the Co-C bond, consistent with the formal reduction of
Co3+ to Co2+ during homolysis. Trans
steric effects were evaluated in a series of benzylcobalt
dimethylglyoxime model complexes in which the bulk of the tertiary
phosphine ligand was varied. An inverse correlation between size and
Co-C bond dissociation energy was noted (19). These results were
consistent with studies on Co-dimethylglyoxime complexes in which
increasing the size of the trans ligand resulted in a
corresponding lengthening of the Co-C bond (20, 21). However, a study
on the association of a series of substituted phosphines to AdoCbi
failed to obtain any evidence for binding, indicating that
alkylcobaloximes are probably poor models for the biologically relevant
corrinoid cofactors (22).
Sirovatka and Finke have compared the thermolysis of AdoCbi in the
presence and absence of N-MeIm as a mimic of the His-on class of isomerases (23). The key finding from these solution studies
is that N-MeIm significantly reduces the proportion of Co-C
bond homolysis from
98% in AdoCbl to ~50% in
AdoCbi·N-MeIm, with the remaining cleavage occurring via
the heterolytic pathway, and it accelerates Co-C bond homolysis and
heterolysis by a factor of 8 and 350, respectively, relative to AdoCbl.
In addition, the presence of N-MeIm leads to an 870-fold and
3 × 104-fold increase in the homolytic and
heterolytic rates, respectively, for Co-C bond cleavage relative to
AdoCbi in the solvent, ethylene glycol.
To address the role of imidazole ligation in a biological context, we
have examined the effect of mutating His-610, the residue provided by
the Propionibacterium shermanni methylmalonyl-CoA mutase. In
this enzyme, His-610 is coordinated to the cobalt and is part of a
hydrogen-bonding triad involving Asp-608 and Lys-604 (Fig. 1 and Ref.
6). Our study indicates that binding of AdoCbl is more severely
affected than binding of AdoCbi, the cofactor lacking the
dimethylbenzimidazole ribose phosphate moiety. We propose that the low
activity of the H610A and H610N mutants of methylmalonyl-CoA mutase
results from weak binding of the cofactor, and that a major role of the
histidine may be in dimethylbenzimidazole displacement and in
organization of the active site for tight cofactor binding.
 |
EXPERIMENTAL PROCEDURES |
Materials--
AdoCbl and methylmalonlyl-CoA were purchased from
Sigma. Radioactive [14C]CH3-malonyl-CoA (56.4 Ci/mol) was purchased from PerkinElmer Life Sciences. All other
chemicals were reagent grade commercial products and were used without
further purification. AdoCbi was synthesized as described previously
(24) and characterized by FAB-MS analysis at the Midwest Center
for Mass Spectroscopy at the University of Nebraska, Lincoln.
Construction of Site-specific Mutants--
A 451-bp
Eco81I-HindIII fragment from pMEX2 containing the
P. shermanii methylmalonyl-CoA mutase gene (Ref. 25,
provided by P. Leadlay at the University of Cambridge) was subcloned
into the pBS vector (Stratagene), which was then used as a template for
creation of mutations by using the strategy supplied with the
QuikChange kit (Stratagene). The following sense mutagenic primers were
employed for PCR: H610A,
GCCAGGACGGTGCCGACCGCGGCCAGAAGGTC and H610N,
GCCAGGACGGTAACGACCGCGGCCAGAAGGTC. The mutant codons are underlined in each case. Each antisense mutagenic primer had
the respective complementary sequence and boundaries that were
identical to that of the sense primers. In each case, a
SacII restriction site was introduced by changing a T to a C
(bold) without changing the identity of the encoded amino acid (Arg), to facilitate selection of transformants containing the mutant sequences. T3 and T7 primers were used to confirm the presence of the
mutation in the pBS plasmid by nucleotide sequence determination.
The mutation-bearing insert was excised from pBS by restriction
digestion with Eco81I and HindIII and partial
PstI restriction digestion and was ligated to the parent
expression plasmid, pMEX2, digested with the same restriction enzymes.
The presence of the mutation was confirmed by nucleotide sequence
determination of both strands as well as by the introduction of a new
SacII site at position 4,112 in the pMEX2 plasmid. DNA
sequencing was performed at the Biotechnology Center Core facility at
the University of Nebraska, Lincoln.
Enzyme Expression and Purification--
The mutant enzymes were
purified through the step preceding reconstitution with cofactor using
a modified procedure described previously for the isolation of wild
type enzyme (26). Butyl-agarose (Sigma) was used for hydrophobic
chromatography instead of phenyl-Sepharose in the second step, and the
Matrex gel blue affinity column was replaced by a POROS anion exchange
column (20HQ, Perspective Biosystem) operated on a BIOcad work station.
A 10 × 5-cm butyl-agarose column was eluted with a linear
gradient ranging from 1.4 to 1 M ammonium sulfate in 50 mM potassium phosphate buffer, pH 7.5, and
methylmalonyl-CoA mutase eluted at ~1.2 M ammonium
sulfate. The enzyme was concentrated and dialyzed against 50 mM potassium phosphate buffer, pH 7.5, before being loaded
onto a POROS 20HQ anion exchange column. The enzyme was eluted with a
linear gradient ranging from 0 to 250 mM NaCl in 50 mM potassium phosphate buffer, pH 7.5, at a flow rate of 10 ml min
1. Methylmalonyl-CoA mutase eluted at ~170
mM NaCl. Protein concentration was determined using the
Bradford reagent (BioRad) with bovine serum albumin as a standard.
Enzyme Assays--
Specific activity of the mutase was
determined in the radiolabeled assay at 37 °C as described
previously (27). 1 unit of activity catalyzes the formation of 1 µmol
of succinyl-CoA min
1 at 37 °C. The concentration of
mutant enzymes was increased 5,000-fold (with H610N) or 1,000-fold
(with H610A) with respect to the wild type enzyme in the standard
assay. Kinetic parameters for the two mutants were determined by
increasing the duration of the fixed timed assay from 3 to 10 min in
the presence of varying concentrations of
[14C]methylmalonyl-CoA (56-2190 µM)
or AdoCbl (from 0.14 to 50 µM).
Attempted Determination of Equilibrium Binding Constants for
Cofactors by Fluorescence Spectroscopy--
Addition of AdoCbl or
AdoCbi to methylmalonyl-CoA mutase results in a decrease in
fluorescence emission at 340 nm and has been used to determine the
equilibrium dissociation constant for the wild type enzyme (28).
However, we were unable to use this method with the two His-610 mutants
to measure a Kd for AdoCbl or AdoCbi because of the
absence of observable changes at low cofactor concentrations and
general quenching of protein fluorescence at high concentrations of
cofactor. We have attributed this fluorescence quenching at micromolar
cofactor concentrations to a filter effect resulting from nonspecific
interactions between the cofactor and the protein (28). This property
interfered with our ability to use fluorescence spectroscopy to
distinguish between binding at the active site versus
nonspecific binding and suggested that the mutant enzymes display
weakened binding affinity.
Equilibrium Binding Constants Measured by UV-Visible Absorption
Spectroscopy--
Binding of AdoCbi to the mutants was followed
spectrophotometrically using a Cary-118 spectrophotometer (Olis
Instruments) in which the cuvette holder was maintained at 4 °C by a
thermostatted water circulator. Methylmalonyl-CoA mutase (24.5 µM) in 150 µl of 50 mM potassium phosphate
buffer, pH 7.5, was employed as a blank. Spectra were recorded between
800 and 306 nm after each addition of AdoCbi (3-5-µl aliquots
prepared in the same buffer), following incubation at 4 °C for 30 min. The final AdoCbi concentration used in these experiments was 90 µM. The change in absorbance at 448 nm at each
concentration of AdoCbi was obtained by subtracting the spectrum of the
same concentration of free AdoCbi in 50 mM potassium
phosphate buffer, pH 7.5. The Kd for AdoCbi was
determined using Equation 1 as described previously (28).
|
(Eq. 1)
|
Estimation of the binding of AdoCbl to the mutants was attempted
using a similar procedure. However, we were able to monitor small
absorbance changes at 460 nm only when very high concentrations of
AdoCbl (0.2-0.4 mM) were added to 150 µM
enzyme. The high background absorption from the free cofactor at these
concentrations limited the feasibility of this experiment but provided
a lower estimate for the Kd for AdoCbl of
300
µM. Absorbance changes could not be detected when low
enzyme concentrations (~25 µM) were employed.
 |
RESULTS |
Steady State Kinetic Properties of Mutant
Proteins--
Methylmalonyl-CoA mutases containing the conservative
mutation H610N or the nonconservative mutation H610A were purified to near homogeneity using conditions developed for the wild type enzyme.
Whereas both mutations had a profound influence on AdoCbl binding
(discussed below), they displayed at most a 2-3-fold higher Km for the cofactor and substrate, respectively
(Table I). The Km for
methylmalonyl-CoA for H610N was indistinguishable from the value for
the wild type enzyme within the limits of experimental error, whereas
the H610A variant had a ~3-fold higher Km. In both
mutants, the Km(app) for AdoCbl was ~2-fold
higher. Both mutations resulted in significant decreases in
kcat, making these measurements experimentally
difficult. Surprisingly, the conservative mutation, H610N, was the
poorer catalyst with a kcat of 0.003 s
1 at 37 °C versus 0.024 s
1
for H610A, albeit both were significantly lower than the value of 120 s
1 at 37 °C for the wild type enzyme. The low
activities of both His-610 mutants raised concerns about possible low
level contamination with wild type enzyme. However, the difference in
the catalytic activities between the two mutants was consistently
observed in every preparation. This would not be expected if low levels
of contaminating wild type enzyme were contributing to the observed activities, because the contribution to both mutants should be similar,
statistically. In addition, the Km values for the
substrate and cofactor for the mutants was distinct from those of the
wild type enzyme (Table I).
Addition of imidazole to the assay mixture up to a concentration of 25 mM did not change the activity of the mutants indicating failure to rescue the functional effects of histidine removal (not
shown). In addition, enzyme activity could not be detected when AdoCbl
was replaced with AdoCbi in the reaction mixture in the presence or
absence of imidazole as observed previously with wild type enzyme (28).
In contrast to the wild type enzyme, which displays an overall
deuterium isotope effect (DV of 5 ± 0.6), neither the
H610A nor the H610N mutant exhibited an isotope effect (data not shown).
Spectral Properties of Methylmalonyl-CoA Mutase Reconstituted with
AdoCbl--
The weak binding of AdoCbl to the His-610 variants of
methylmalonyl-CoA mutase precluded an accurate determination of the Kd for the cofactor. The spectrum of H610A
reconstituted with AdoCbl was weak and had features corresponding to a
mixture of base-off AdoCbl (460 nm) and hydroxycobalamin (350 and 535 nm) as shown in Fig. 2. The reconstitution procedure used to generate this spectrum is routinely employed with wild type methylmalonyl-CoA mutase and AdoCbl in the laboratory and does not lead to loss of the
adenosyl group. These results indicate that the His-610 mutants display
enhanced lability of the Co-C bond leading to inactive enzyme
containing hydroxycobalamin, a property that is not exhibited by the
wild type enzyme. A similar lability has been observed with wild type
enzyme reconstituted with AdoCbi, which is in the His-off conformation
in the active site (28).
Spectral Properties of Methylmalonyl-CoA Mutase Reconstituted
with AdoCbi--
Binding of AdoCbi to wild type mutase results in an
increase in absorption across the entire spectral range as has
been observed previously for AdoCbl (28). In contrast, the
difference spectrum of the [His-610]enzyme·AdoCbi complex
obtained following successive additions of cofactor aliquots showed a
number of distinct changes (see Fig. 3). These included increases in
absorption at 360, 448, 507, and 535 nm and revealed conversion of
AdoCbi to hydroxycobinamide in the presence of the enzyme. These
results indicate that the absence of the coordinating histidine ligand
enhances cleavage of the Co-C bond of AdoCbi as also seen with AdoCbl
(see above). The increase in absorbance at 448 nm accompanying cofactor
binding was plotted as a function of the concentration of free cofactor and yielded a Kd of 49.5 ± 2.7 µM for H610A (Fig. 3, inset) and 55.8 ± 5.4 µM for H610N (Table I).
 |
DISCUSSION |
This study was originally designed to evaluate the role of
trans effects in variants of methylmalonyl-CoA mutase in
which the lower, protein-derived ligand, His-610, was either removed (H610A) or altered (H610N). Both changes had profound effects on the
cofactor dissociation constant and on kcat but
had modest effects on substrate and cofactor Km
values. Thus, the H610A and H610N mutants displayed 5,000- and
40,000-fold diminution in kcat, respectively, as
compared with the wild type enzyme, indicating a change in the
rate-limiting step that is believed to be product dissociation for the
wild type enzyme (29). Our inability to measure the binding constant
for AdoCbl by difference UV-visible electronic spectroscopy puts a
lower limit on the Kd values for the mutants at
300 µM, indicating that the equilibrium dissociation
constant has been weakened by
1,700-fold.
The marked difference in the apparent Km and
Kd for AdoCbl displayed by the two His-610 mutants
is surprising. However, very similar behavior has been reported for the
corresponding mutants in glutamate mutase, H16G and H16Q, where the
Km is increased 3-5-fold whereas the
Kd is increased an estimated 50-fold (30). As
pointed out by Chen and Marsh (30), a minimal kinetic scheme describing
the cofactor and substrate binding steps and catalysis reveals that
Km is a complex kinetic term that could in principle
be equivalent to, larger, or smaller than Kd. In
wild type methylmalonyl-CoA mutase, the Kd and
apparent Km for AdoCbl are equivalent (28, 31). The
large difference between the values of the two kinetic constants
displayed by the mutants is consistent with a significant change in the
binding affinity for AdoCbl, which in turn impacts
kcat, presumably by changing the rate-limiting step. This conclusion is supported by suppression of the overall deuterium isotope effect in the mutant enzymes in contrast to that of
wild type enzyme that displays a DV of 5 ± 0.6 (32).
This is consistent with a step such as cofactor binding limiting catalysis.
The phenotypes of the His-610 mutants reported in this study are in
sharp contrast to the mild effects observed when the His-off state is
achieved using the cofactor analog, AdoCbi-GDP (32). The latter is a
biosynthetic intermediate in the assembly of cobalamin, and we have
previously shown that it supports catalysis by methylmalonyl-CoA mutase. Binding of AdoCbi-GDP results in retention of the 460-nm absorption maximum observed for the cofactor free in solution indicating that His-610 does not move into coordination position when
this cofactor analog binds. This is confirmed by the EPR spectrum of
bound cob(II)inamide-GDP obtained by photolysis of methylmalonyl-CoA
mutase reconstituted with AdoCbi-GDP in which the
ACo-N value for the hyperfine interaction is 144 G, and superhyperfine splittings associated with axial nitrogen
ligation are absent. The Kd for AdoCbi-GDP is 4.9 µM versus 0.17 µM for AdoCbl, and the kcat is decreased from 73 s
1 to 18 s
1 at 30 °C. The spectra of the
enzyme in the presence and absence of high concentrations of substrate
do not show significant changes (32). Because the
kcat under maximal velocity conditions is only
4-fold lower with AdoCbi-GDP than with AdoCbl, the lack of observable
spectral changes argues against transient coordination by His-610 under
catalytic turnover conditions.
Thus, the His-off state achieved by site-directed mutagenesis as in the
H610A mutant (and most likely also in the H610N variant), is
functionally different from the His-off state obtained with the
cofactor analog, AdoCbi-GDP, and raises the question of what the role
of His-610 really is. One possibility is that electrostatic interactions between His-610, Asp-608, and Lys-604 may play an important role in catalysis by maintaining a high affinity cofactor binding site (Fig. 1) and that the
absence of this hydrogen-bonding network compromises structural
integrity in the holoenzyme. This is supported by the observed increase
in the rate of Co-C bond cleavage of bound AdoCbl and AdoCbi (Figs.
2 and 3) in
comparison to wild type enzyme, where geminate recombination of the
homolysis products is greatly favored in the absence of substrate
(4).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Conformations of cobalamin bound to the
active site of methylmalonyl-CoA mutase (A) and of
cobinamide (B). The figures were generated from
the protein data bank file, 1REQ1, and the upper axial deoxyadenosine
ligand is absent. In A, the triad of residues that form a
hydrogen-bonding network, Lys-604, Asp-608, and His-610 are shown. When
AdoCbi binds to the mutase active site, His-610 is not coordinated to
the cobalt.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
Spectrum of H610A reconstituted with
AdoCbl. Enzyme (150 µM) in 50 mM
potassium phosphate buffer, pH 7.5, was mixed with 3 mM
AdoCbl in the dark and kept on ice for 2 h. Excess cofactor was
removed by dialysis against the same buffer. The spectrum obtained has
absorption features corresponding to a mixture of hydroxycobalamin (358 and 535 nm) and base-off AdoCbl (460 nm) as indicated by
arrows.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 3.
Binding of AdoCbi to H610A
methylmalonyl-CoA mutase determined by electronic absorption
spectroscopy. The stack plot represents difference UV-visible
absorption spectra obtained by successive addition of AdoCbi aliquots
to the H610N mutant (24.5 µM) in 50 mM
potassium phosphate buffer, pH 7.5. The arrows indicate
difference absorption maxima at 360, 448, 507, and 535 nm.
Inset, dependence of absorption change at 448 nm on the
concentration of AdoCbi. The data were fit to Equation 1 and yielded a
Kd of 49.5 ± 2.7 µM.
|
|
A second possibility is suggested by the magnitude of the impairment in
the equilibrium binding constant when the nucleotide tail is absent as
in AdoCbi (~80-fold), which is significantly smaller than when the
tail is present as in the natural cofactor, AdoCbl (
1700-fold,
Table I). This suggests that the histidine may be important in binding
of the cofactor, specifically in the ligand displacement reaction that
must precede docking of AdoCbl to the active site of methylmalonyl-CoA
mutase (Fig. 4). The equilibrium association constant for the intramolecular base,
dimethylbenzimidazole, in AdoCbl is reported to be 14.3 at 25 °C
(33) and the pKa for this ligand in AdoCbl is 3.7 (34). Thus, at physiological pH, the cofactor exists predominantly in
the dmb-on conformation, and the dimethylbenzimidazole must be
displaced to achieve the dmb-off conformation in the active site.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
Model showing potential role of His-610 in
displacement of dimethylbenzimidazole preceding docking of AdoCbl in
the mutase active site. A, predocking conformations of
cobalamin in solution and residues 1-30 of apoglutamate mutase (PDB:
1BE1) in which His-16, the residue that coordinates to the
cofactor is shown in stick display. B,
postdocking conformations of cobalamin and residues 599-625 of
methylmalonyl-CoA mutase (PDB: 1REQ1) in which His-610, the residue
that coordinates to the cofactor, is shown in stick
display.
|
|
We have previously characterized the pH dependence of AdoCbl binding to
wild type mutase by stopped-flow fluorescence spectroscopy and found it
to be associated with a pKa of 7.3 (28). In
contrast, when the truncated cofactor analog AdoCbi was employed, binding of the cofactor was complete within the instrument dead time,
suggesting that dissociation of the dimethylbenzimidazole ligand is the
slow step in the docking of the native cofactor to the mutase active
site. Based on the results reported here on the His-610 mutants, we
propose a model in which the coordinating histidine plays a role in
promoting the dmb-off conformation and thereby catalyzes cofactor
binding (Fig. 4). The observed pKa of 7.3 associated
with AdoCbl binding would be consistent with ionization of a histidine residue.
Comparison of the highly homologous structures of the B12
binding domains of glutamate mutase determined in the absence of the
cofactor (35) and of methylmalonyl-CoA mutase solved in the presence of
the cofactor (6), reveals that the domain is largely preorganized and
that the ligand histidine in both cases is located on a loop (Fig. 4).
The difference, however, is that in the presence of B12,
the loop leads to a relatively long
-helix that interacts with the
nucleotide tail; however, this stretch of amino acids is largely
disordered in the absence of B12. Thus, binding of the
cofactor appears to shift the equilibrium toward a more stable
-helix extending from the loop carrying the ligand histidine (36)
and presumably helps position it for coordination.
It is noteworthy that the properties of the histidine ligand mutation,
H759G, in methylcobalamin-dependent methionine synthase are
distinct from those exhibited by the AdoCbl-dependent
methylmalonyl-CoA mutase and glutamate mutase with respect to cofactor
binding. Tight binding of the cofactor is retained by this mutant
although the catalytic efficiency of the enzyme is greatly impaired
(37). The ligand histidine in methionine synthase is a member of a
histidine-aspartate-serine triad of residues that appears to be
important as a proton shunt that facilitates cycling of the cofactor
between six-coordinate methylcobalamin and four-coordinate cob(I)alamin
states (9). An analogous role is not expected for the isomerases, and
indeed, the serine is not conserved in these enzymes. In fact, the
significance of the His-on conformation in the subclass of isomerases
that exhibit this binding motif is unclear, and it has been speculated that it may represent an evolutionary vestige inherited from the probably more ancient B12-dependent
methyltransferase family of enzymes (3). In a second subclass of
isomerases, AdoCbl is in fact bound in the dmb-on conformation (11, 12,
38) revealing that catalysis of isomerase chemistry is not uniquely
dependent on the presence of the histidine versus
dimethylbenzimidazole ligand.
Although reconstitution of most B12-dependent
enzymes with their respective cofactors is readily achieved in
vitro, little is known about the process in vivo, and
in particular, whether or not B12 chaperones are involved.
Because intermediates in the cofactor biosynthetic pathway have been
shown to bind tightly to several B12 enzymes, facilitation
of this process by proteins would appear to be important for achieving
specificity. Depending on the class of B12 enzymes,
discrimination between the ligand identities at the upper axial
position and retention or replacement of the ligand at the lower axial
position will be important determinants for cofactor binding.
In summary, characterization of the His-610 mutants of
methylmalonyl-CoA mutase in this study in combination with our previous studies on the catalysis of this reaction by AdoCbi-GDP reconstituted enzyme that yields the His-off conformation (32), suggests a role for
the histidine residue that has not been considered previously. We
propose that the histidine residue may be involved in catalyzing the
conformational change from the dmb-on to dmb-off state that must
precede AdoCbl docking in the active site and that the primary influence of the histidine residue is on cofactor binding rather than catalysis.
 |
FOOTNOTES |
*
This work was supported by Grant DK45776 from the National
Institutes of Health (to R. B.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
An Established Investigator of the American Heart Association. To
whom correspondence should be addressed. Tel.: 402-472-2941; Fax:
402-472-7842; E-mail: rbanerjee1@unl.edu.
Published, JBC Papers in Press, March 13, 2002, DOI 10.1074/jbc.M111809200
 |
ABBREVIATIONS |
The abbreviations used are:
AdoCbl, 5'-deoxyadenosylcobalamin or coenzyme B12;
dAdo, 5'-deoxyadenosine;
AdoCbi, 5'-deoxyadenosylcobinamide;
AdoCbi-GDP, 5'-deoxyadenosylcobinamide guanosine diphosphate;
N-MeIm, N-methylimidazole;
dmb, dimethylbenzimidazole.
 |
REFERENCES |
| 1.
|
Waddington, M. D.,
and Finke, R. G.
(1993)
J. Am. Chem. Soc.
115,
4629-4640[CrossRef]
|
| 2.
|
Hay, B. P.,
and Finke, R. G.
(1987)
J. Am. Chem. Soc.
109,
8012-8018[CrossRef]
|
| 3.
|
Banerjee, R.
(2001)
Biochemistry
40,
6191-6198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Chowdhury, S.,
and Banerjee, R.
(2000)
Biochemistry
39,
7998-8006[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Lenhert, P. G.,
and Hodgkin, D. C.
(1961)
Nature
192,
937-938[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Mancia, F.,
Keep, N. H.,
Nakagawa, A.,
Leadlay, P. F.,
McSweeney, S.,
Rasmussen, B.,
Bösecke, P.,
Diat, O.,
and Evans, P. R.
(1996)
Structure
4,
339-350[Medline]
[Order article via Infotrieve]
|
| 7.
|
Reitzer, R.,
Gruber, K.,
Jogl, G.,
Wagner, U. G.,
Bothe, H.,
Buckel, W.,
and Kratky, C.
(1999)
Structure Fold Des.
7,
891-902[Medline]
[Order article via Infotrieve]
|
| 8.
|
Stupperich, E.,
Eisinger, H. J.,
and Albracht, S. P. J.
(1990)
Eur. J. Biochem.
193,
105-109[Medline]
[Order article via Infotrieve]
|
| 9.
|
Drennan, C. L.,
Huang, S.,
Drummond, J. T.,
Matthews, R.,
and Ludwig, M. L.
(1994)
Science
266,
1669-1674[Abstract/Free Full Text]
|
| 10.
|
Yamanishi, M.,
Yamada, S.,
Muguruma, H.,
Murakami, Y.,
Tobimatsu, T.,
Ishida, A.,
Yamauchi, J.,
and Toraya, T.
(1998)
Biochemistry
37,
4799-4803[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Abend, A.,
Bandarian, V.,
Nitsche, R.,
Stupperich, E.,
Retey, J.,
and Reed, G. H.
(1999)
Arch. Biochem. Biophys.
370,
138-141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Lawrence, C. C.,
Gerfen, G. J.,
Samano, V.,
Nitsche, R.,
Robins, M. J.,
Retey, J.,
and Stubbe, J.
(1999)
J. Biol. Chem.
274,
7039-7042[Abstract/Free Full Text]
|
| 13.
|
Grate, J. H.,
and Schrauzer, G. N.
(1979)
J. Am. Chem. Soc.
101,
4601-4611[CrossRef]
|
| 14.
|
Marzilli, L. G.,
Toscano, J.,
Randaccio, L.,
Bresciani-Pahor, N.,
and Calligaris, M.
(1979)
J. Am. Chem. Soc.
101,
6754-6756[CrossRef]
|
| 15.
| Chemaly, S. M., and Pratt, J. M. (1980) J. Chem.
Soc. Dalton Trans. 2274-2281
|
| 16.
|
Ng, F. T. T.,
Rempel, G. L.,
and Halpern, J.
(1982)
J. Am. Chem. Soc.
104,
621-623[CrossRef]
|
| 17.
|
Glusker, J. P.
(1982)
in
B12
(Dolphin, D., ed), Vol. 1
, pp. 23-106, Wiley, New York
|
| 18.
|
Brown, K. L.,
and Brooks, H. B.
(1991)
Inorg. Chem.
30,
3420-3430[CrossRef]
|
| 19.
|
Geno, M. K.,
and Halpern, J.
(1987)
J. Am. Chem. Soc.
109,
1238-1240[CrossRef]
|
| 20.
|
Randaccio, L.,
Bresciani-Pahor, N.,
Toscano, P. J.,
and Marzilli, L. G.
(1980)
J. Am. Chem. Soc.
102,
7373-7375[CrossRef]
|
| 21.
|
Summers, M. F.,
Toscano, P. J.,
Bresciani-Pahor, N.,
Nardin, G.,
Randaccio, L.,
and Marzilli, L. G.
(1983)
J. Am. Chem. Soc.
105,
6259-6293[CrossRef]
|
| 22.
|
Garr, C. D.,
Sirovatka, J. M.,
and Finke, R. G.
(1996)
Inorg. Chem.
35,
5912-5922[CrossRef]
|
| 23.
|
Sirovatka, J. M.,
and Finke, R. G.
(1997)
J. Am. Chem. Soc.
119,
3057-3067[CrossRef]
|
| 24.
|
Ishida, A.,
and Toraya, T.
(1993)
Biochemistry
32,
1535-1540[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
McKie, N.,
Keep, N. H.,
Patchett, M. L.,
and Leadlay, P. F.
(1990)
Biochem. J
269,
293-298[Medline]
[Order article via Infotrieve]
|
| 26.
|
Padmakumar, R.,
and Banerjee, R.
(1995)
J. Biol. Chem.
270,
9295-9300[Abstract/Free Full Text]
|
| 27.
|
Taoka, S.,
Padmakumar, R.,
Lai, M.-t.,
Liu, H.-w.,
and Banerjee, R.
(1994)
J. Biol. Chem.
269,
31630-31634[Abstract/Free Full Text]
|
| 28.
|
Chowdhury, S.,
and Banerjee, R.
(1999)
Biochemistry
38,
15287-15294[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Padmakumar, R.,
Padmakumar, R.,
and Banerjee, R.
(1997)
Biochemistry
36,
3713-3718[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Chen, H. P.,
and Marsh, E. N.
(1997)
Biochemistry
36,
7884-7889[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Maiti, N.,
Widjaja, L.,
and Banerjee, R.
(1999)
J. Biol. Chem.
274,
32733-32737[Abstract/Free Full Text]
|
| 32.
|
Chowdhury, S.,
Thomas, M. G.,
Escalante-Semerena, J. C.,
and Banerjee, R.
(2001)
J. Biol. Chem.
276,
1015-1019[Abstract/Free Full Text]
|
| 33.
|
Hay, B. P.,
and Finke, R. G.
(1984)
Polyhedron
7,
1469[CrossRef]
|
| 34.
|
Brown, K. L.,
and Hakimi, J. M.
(1984)
J. Am. Chem. Soc.
106,
7894-7899[CrossRef]
|
| 35.
|
Tollinger, M.,
Konrat, R.,
Hilbert, B. H.,
Marsh, E. N. G.,
and Krauetler, B.
(1998)
Structure
6,
1021-1033[Medline]
[Order article via Infotrieve]
|
| 36.
|
Tollinger, M.,
Eichmuller, C.,
Konrat, R.,
Huhta, M. S.,
Marsh, E. N.,
and Krautler, B.
(2001)
J. Mol. Biol.
309,
777-791[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Jarrett, J. T.,
Amaratunga, M.,
Drennan, C. L.,
Scholten, J. D.,
Sands, R. H.,
Ludwig, M. L.,
and Matthews, R. G.
(1996)
Biochemistry
35,
2464-2475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Shibata, N.,
Masuda, J.,
Tobimatsu, T.,
Toraya, T.,
Suto, K.,
Morimoto, Y.,
and Yasuoka, N.
(1999)
Structure Fold Des.
7,
997-1008[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.